Heart Failure Management: The Neural Pathways

Edoardo Gronda

ISBN 10: 3319249916 / ISBN 13: 9783319249919

Published by Springer, Springer International Publishing, 2016

About this Item

Druck auf Anfrage Neuware - Printed after ordering - This book describes the most recent insights into heart failure and the role played by autonomic nervous system pathophysiology in it, discussing the therapeutic implications. While current therapeutic approaches are able to control the effects of excessive adrenergic activation in heart failure syndrome, the underlying abnormalities of adrenergic control remain unaltered and can still cause progression to unmanageable end-stage heart failure. New therapeutic pathways are therefore being explored with a view to developing interventions that can directly modulate adrenergic over-activity and restore a more appropriate balance in neural control of the cardiovascular system. The book opens by examining current heart failure therapies. Advances in our understanding of autonomic regulation/dysregulation in heart failure are then discussed in detail, in the context of the search for more effective therapies. A concluding section addresses the role of autonomic nervous system denervation in heart failure. The authors are top scientists from leading research centers.

Seller Inventory # 9783319249919

Bibliographic Details

• Title: Heart Failure Management: The Neural Pathways
• Publisher: Springer, Springer International Publishing
• Publication Date: 2016
• Language: English
• ISBN 10: 3319249916
• ISBN 13: 9783319249919
• Binding: Buch
• Condition: Neu
• Dimensions: 241W x 160H x 17D millimeters 241 millimeters width by 160 millimeters height by 17 millimeters depth
• Weight: 547 grams

About this title

Synopsis

This book describes the most recent insights into heart failure and the role played by autonomic nervous system pathophysiology in it, discussing the therapeutic implications. While current therapeutic approaches are able to control the effects of excessive adrenergic activation in heart failure syndrome, the underlying abnormalities of adrenergic control remain unaltered and can still cause progression to unmanageable end-stage heart failure. New therapeutic pathways are therefore being explored with a view to developing interventions that can directly modulate adrenergic over-activity and restore a more appropriate balance in neural control of the cardiovascular system. The book opens by examining current heart failure therapies. Advances in our understanding of autonomic regulation/dysregulation in heart failure are then discussed in detail, in the context of the search for more effective therapies. A concluding section addresses the role of autonomic nervous system denervation in heart failure. The authors are top scientists from leading research centers.

About the Author

Dr. Edoardo Gronda is Director of IRCCS Clinical Research Cardiology Unit and San Giuseppe Hospital (MultiMedica Group) in Milan, Italy, since 2010. His interest in heart failure started in 1984 when he staged 6 months at the London University Hospital Ontario (Canada), training on Heart Transplant program. Back to Italy he became one of the earliest Italian experts in heart failure as a sub-specialty, running the Heart failure/Heart Transplant Medicine Program at the Niguarda General Hospital, Milan, until 1999.

Emilio Vanoli is Associate Professor of Cardiology at the University of Pavia (Italy) and Adjunct Associate Professor of Physiology at the University of Oklahoma. He is Director of the outpatient Heart Failure Clinic, IRCCS MultiMedica, Sesto S. Giovanni, Milan (Italy).  

Alexandru Costea is Medical Director of Electrophysiology at the University of Cincinnati Hospital. He is Full Professor at the University of the Cincinnati School of Medicine and Associate Program Director of the Electrophysiology Fellowship Program since 2010. Furthermore, he is an expert in atrial fibrillation ablations and ventricular tachycardia ablations.